Abstract:The serine-threonine kinase, tumor progression locus 2 (Tpl2, also known as Map3k8/Cot), is a potent inflammatory mediator that drives the production of TNFα, IL-1β, and IFNγ. We previously demonstrated that Tpl2 regulates TCR signaling and modulates T helper cell differentiation. However, very little is known about how Tpl2 modulates the development of regulatory T cells (Tregs). Tregs are a specialized subset of T cells that express FoxP3 and possess immunosuppressive properties to limit excess inflammation. Because of the documented role of Tpl2 in promoting inflammation, we hypothesized that Tpl2 antagonizes Treg development and immunosuppressive function. Herein, we demonstrate that Tpl2 constrains the development of inducible Tregs (iTregs). Tpl2 naïve CD4 T cells preferentially develop into FoxP3 iTregs in vitro as well as in vivo in a murine model of OVAinduced systemic tolerance. Treg biasing of Tpl2 T cells depended upon the TCR signal strength and corresponded with reduced activation of the mammalian target of rapamycin (mTOR) pathway. Importantly, Tpl2 Tregs have basally increased expression of FoxP3 and immunosuppressive molecules, IL-10 and cytotoxic T lymphocyteassociated protein 4 (CTLA-4). Furthermore, they were more immunosuppressive in vivo in a T cell transfer model of colitis, as evidenced by reducing effector T cell accumulation, systemic production of inflammatory cytokines, and colonic inflammation. These results demonstrate that Tpl2 promotes inflammation in part by constraining FoxP3 expression and Treg immunosuppressive functions. Overall these findings suggest that Tpl2 inhibition could be used to preferentially drive Treg induction and thereby limit inflammation in a variety of autoimmune diseases. INTRODUCTION Pathogenesis of a number of autoimmune diseases is attributed to self-reactive T cells that recognize self-antigens and trigger organ-specific damage (1). Regulatory T cells are a specialized lineage of T cells with immunosuppressive properties. The forkhead box P3 (FoxP3) transcription factor is important in specifying this lineage (2,3), and humans with mutations in the Foxp3 gene develop severe multi-organ autoimmune disease including autoimmune enteropathy, dermatitis, thyroiditis, and type I diabetes (4). This syndrome is highly homologous to that observed in scurfy mice that also harbor mutations within the Foxp3 gene (5). Tregs arise naturally in the thymus (natural Tregs, nTregs or thymus-derived Tregs, tTregs) or can be induced from naïve conventional T cells in the periphery (inducible Tregs; iTregs) (6-9). Both types of FoxP3 Tregs exhibit critical immunoregulatory functions to maintain central and peripheral http://www.jbc.org/cgi/doi/10.1074/jbc.M116.718783 The latest version is at JBC Papers in Press. Published on June 3, 2016 as Manuscript M116.718783 Copyright 2016 by The American Society for Biochemistry and Molecular Biology, Inc. by gest on N ovem er 8, 2017 hp://w w w .jb.org/ D ow nladed from

Ndfip1 Restricts Mtorc1 Signalling And Glycolysis In Regulatory T Cells To Prevent Autoinflammatory Disease

Neuropilin-1 Identifies a New Subpopulation of TGF--Induced Foxp3<SUP>+</SUP> Regulatory T Cells With Potent Suppressive Function and Enhanced Stability During Inflammation

Ndfip Proteins Control Treg Cell Fate and Function to Prevent Autoimmune Disease.

Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells

Nemo-like Kinase Drives Foxp3 Stability and is Critical for Maintenance of Immune Tolerance by Regulatory T Cells.

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

T Cell Signaling Targets for Enhancing Regulatory or Effector Function.

Neuropilin-1 Identifies a New Subpopulation of TGF-β-Induced Foxp3+ Regulatory T Cells With Potent Suppressive Function and Enhanced Stability During Inflammation

TIF1γ regulates stability of T regulatory cells during inflammation

Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation

Foxp1 is Critical for the Maintenance of Regulatory T-cell Homeostasis and Suppressive Function.

Nedd4 Family Interacting Proteins Activate Ubiquitylation Pathways to Limit ERK Signaling Following TCR Engagement (IRM7P.702)

Inflammation Negatively Regulates FOXP3 and Regulatory T-cell Function Via DBC1.

PDK1 is Required for Maintenance of CD4+ Foxp3+ Regulatory T Cell Function

Tumor progression locus 2 ( Tpl 2 ) activates the mTOR pathway , inhibits FoxP 3 expression and limits Treg immunosuppressive functions

TGF-β1 Maintains Foxp3 Expression and Inhibits Glycolysis in Natural Regulatory T Cells Via PP2A-mediated Suppression of Mtor Signaling.

Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics

Regulation of FoxO1 by mTORC2 negatively controls Toll-like receptor responses (111.24)

Nutrient Mtorc1 Signaling Underpins Regulatory T Cell Control of Immune Tolerance

Nuclear receptor corepressor 1 controls regulatory T cell subset differentiation and effector function